Loading clinical trials...
Loading clinical trials...
A Multiple-dose, Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dysport for the Treatment of Pain Associated With Hallux Abducto Valgus
Conditions
Interventions
Botulinum toxin type A
Placebo
Locations
29
United States
NEA Baptist Clinic
Jonesboro, Arkansas, United States
Applied Research Center of Arkansas, Inc
Little Rock, Arkansas, United States
Center for Clinical Research Inc.
Castro Valley, California, United States
Limb Preservation Platform, Inc.
Fresno, California, United States
Southwestern Academic Limb Salvage Alliance
Los Angeles, California, United States
Foot and Ankle Clinic
Los Angeles, California, United States
Start Date
June 19, 2018
Primary Completion Date
December 17, 2019
Completion Date
May 22, 2020
Last Updated
July 2, 2021
Lead Sponsor
Ipsen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions